000 | 01942 a2200541 4500 | ||
---|---|---|---|
005 | 20250515131711.0 | ||
264 | 0 | _c20081118 | |
008 | 200811s 0 0 eng d | ||
022 | _a1476-5594 | ||
024 | 7 |
_a10.1038/onc.2008.258 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aZhuang, D | |
245 | 0 | 0 |
_aC-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells. _h[electronic resource] |
260 |
_bOncogene _cNov 2008 |
||
300 |
_a6623-34 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCellular Senescence _xdrug effects |
650 | 0 | 4 |
_aCyclin-Dependent Kinase Inhibitor p16 _xgenetics |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 | _aGene Deletion |
650 | 0 | 4 | _aGene Expression |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMelanocytes _xmetabolism |
650 | 0 | 4 |
_aMelanoma _xenzymology |
650 | 0 | 4 |
_aMitogen-Activated Protein Kinase Kinases _xantagonists & inhibitors |
650 | 0 | 4 |
_aNeoplasm Metastasis _xgenetics |
650 | 0 | 4 | _aPhenotype |
650 | 0 | 4 |
_aPhosphatidylinositol 3-Kinases _xmetabolism |
650 | 0 | 4 | _aPhosphoinositide-3 Kinase Inhibitors |
650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
650 | 0 | 4 |
_aProto-Oncogene Proteins B-raf _xgenetics |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-myc _xgenetics |
650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xgenetics |
650 | 0 | 4 |
_aras Proteins _xgenetics |
700 | 1 | _aMannava, S | |
700 | 1 | _aGrachtchouk, V | |
700 | 1 | _aTang, W-H | |
700 | 1 | _aPatil, S | |
700 | 1 | _aWawrzyniak, J A | |
700 | 1 | _aBerman, A E | |
700 | 1 | _aGiordano, T J | |
700 | 1 | _aProchownik, E V | |
700 | 1 | _aSoengas, M S | |
700 | 1 | _aNikiforov, M A | |
773 | 0 |
_tOncogene _gvol. 27 _gno. 52 _gp. 6623-34 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/onc.2008.258 _zAvailable from publisher's website |
999 |
_c18154346 _d18154346 |